1,152 material Form 8-K filings that 918 companies we cover made with the SEC in October 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
HCA Healthcare reported third-quarter 2025 revenue of $19.161 billion, up 9.6%, and net income attributable to HCA of $1.643 billion, or $6.96 per diluted share, compared with $4.88 a year earlier. The company raised its 2025 diluted EPS guidance to $27.00 to $28.00 per share, from $25.50 to $27.00, and declared a $0.72 quarterly dividend.
Q3 2025 revenue was $19.161 billion, up from $17.487 billion; diluted EPS was $6.96 versus $4.88.
Revised 2025 diluted EPS guidance is $27.00 to $28.00, up from $25.50 to $27.00 set on July 25, 2025.
Revised 2025 Adjusted EBITDA guidance is $15.250 billion to $15.650 billion, up from $14.700 billion to $15.300 billion.
Quarterly dividend of $0.72 per share is payable December 29, 2025, to holders of record on December 15, 2025.
Booz Allen Hamilton reported fiscal second-quarter 2026 results for the quarter ended September 30, 2025, with revenue down 8.1 percent to $2.9 billion and adjusted diluted EPS of $1.49, down 17.7 percent. The company lowered its full-year fiscal 2026 guidance and attributed the weaker results to a continued funding slowdown, which shareholders will weigh against the record $40 billion backlog.
Q2 net income was $175 million, down 55.1 percent; adjusted diluted EPS was $1.49, down 17.7 percent
Fiscal 2026 revenue guidance cut to $11.3 billion to $11.5 billion from $12.0 billion to $12.5 billion
Fiscal 2026 adjusted diluted EPS guidance lowered to $5.45 to $5.65 from $6.20 to $6.55
Total backlog reached a record $40 billion, up 2.9 percent; quarterly dividend of $0.55 per share is payable December 2, 2025
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.